PBH Stock Summary and Trading Ideas (Prestige Consumer Healthcare | NYSE:PBH)

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

What symbol and exchange does Prestige Consumer Healthcare shares trade?

Prestige Consumer Healthcare trades on the NYSE stock market under the symbol PBH.

What is Prestige Consumer Healthcare stock price doing today?

As of September 10, 2026, PBH stock price declined to $47.34 with 450,744 million shares trading.

What is Prestige Consumer Healthcare's Beta?

PBH has a beta of 0.40, meaning it tends to be less sensitive to market movements. PBH has a correlation of 0.03 to the broad based SPY ETF.

How much is Prestige Consumer Healthcare worth?

PBH has a market cap of $2.24 billion. This is considered a Mid Cap stock.

How much money does Prestige Consumer Healthcare make?

Last quarter Prestige Consumer Healthcare reported $266 million in Revenue and $.98 earnings per share. This beat revenue expectation by $16 million and exceeded earnings estimates by $.11.

What is the highest and lowest price Prestige Consumer Healthcare traded in the last 3 year period?

In the last 3 years, PBH traded as high as $90.04 and as low as $42.62.

What are the top ETFs holding Prestige Consumer Healthcare?

The top ETF exchange traded funds that PBH belongs to (by Net Assets): VTI, VB, VBR, VXF, SPSM.

Is Prestige Consumer Healthcare (PBH) a good investment?

PBH has underperformed the market in the last year with a price return of -27.2% while the SPY ETF gained +17.3%. PBH has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -3.6% and -7.6%, respectively, while the SPY returned +4.7% and -1.7%, respectively.

What are the support and resistance levels for Prestige Consumer Healthcare (PBH)?

PBH support price is $47.62 and resistance is $49.78 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PBH shares will trade within this expected range on the day.